Review Article
Targeting CDK4/6 in mantle cell lymphoma
Annals of Lymphoma
2020;
4:
1
.
(31 March 2020)
Editorial
Better understanding and new challenges in high grade lymphomas
Annals of Lymphoma
2019;
3:
13
.
(18 December 2019)
Case Report
PD-L1 expression and response to nivolumab in a case of relapsed/refractory lymphomatoid granulomatosis
Annals of Lymphoma
2019;
3:
12
.
(18 December 2019)
News
Application of the CARE guideline as reporting standard in the Annals of Lymphoma
Annals of Lymphoma
2019;
3:
11
.
(12 December 2019)
Review Article
New drugs for the management of relapsed or refractory diffuse large B-cell lymphoma
Annals of Lymphoma
2019;
3:
10
.
(27 November 2019)
Review Article
A survey of the therapeutic landscape in peripheral T-cell lymphomas: the importance of expert hematopathology review in the era of targeted therapies and precision medicine
Annals of Lymphoma
2019;
3:
9
.
(21 November 2019)
Review Article
Front-line therapy in elderly patients with mantle cell lymphoma
Annals of Lymphoma
2019;
3:
8
.
(25 July 2019)
Review Article
Risk stratification and management algorithms for patients with diffuse large B-cell lymphoma and CNS involvement
Annals of Lymphoma
2019;
3:
7
.
(18 July 2019)
Review Article
Immunologic treatment strategies in mantle cell lymphoma: checkpoint inhibitors, chimeric antigen receptor (CAR) T-cells, and bispecific T-cell engager (BiTE) molecules
Annals of Lymphoma
2019;
3:
6
.
(27 May 2019)
Case Report
Sensorineural hearing loss in a patient with follicular lymphoma treated with bendamustine and rituximab
Annals of Lymphoma
2019;
3:
5
.
(16 May 2019)
Review Article
Venetoclax for the treatment of mantle cell lymphoma
Annals of Lymphoma
2019;
3:
4
.
(15 April 2019)
Review Article
Mantle cell lymphoma pathology update in the 2016 WHO classification
Annals of Lymphoma
2019;
3:
3
.
(18 March 2019)
Review Article
Is there a role for immunomodulatory drugs in the treatment of mantle cell lymphoma?
Annals of Lymphoma
2019;
3:
2
.
(14 January 2019)
Review Article
Aggressive B-cell lymphomas—from morphology to molecular pathogenesis
Annals of Lymphoma
2019;
3:
1
.
(08 January 2019)
Review Article
Risk stratification of mantle cell lymphoma (MCL)
Annals of Lymphoma
2018;
2:
10
.
(21 December 2018)
Review Article
Immunotherapy in non-Hodgkin lymphoma
Annals of Lymphoma
2018;
2:
9
.
(21 December 2018)
Review Article
Diffuse large B-cell lymphoma—who should we FISH?
Annals of Lymphoma
2018;
2:
8
.
(28 November 2018)
Review Article
Novel markers for determining risk and evaluation of minimal residual disease in diffuse large B-cell lymphoma
Annals of Lymphoma
2018;
2:
7
.
(16 October 2018)
Case Report
Is reimplant after breast implant-associated anaplastic large cell lymphoma a safe procedure? Yes, no, or may be?
Annals of Lymphoma
2018;
2:
6
.
(02 August 2018)
Editorial
Extranodal NK/T cell lymphoma-associated hemophagocytic syndrome: where do we stand?
Annals of Lymphoma
2018;
2:
5
.
(24 May 2018)
Review Article
Bendamustine in peripheral T-cell lymphoma
Annals of Lymphoma
2018;
2:
4
.
(06 May 2018)
Review Article
Pembrolizumab in systemic and cutaneous T-cell lymphoma
Annals of Lymphoma
2018;
2:
3
.
(10 April 2018)
Editorial
A new tool in the cancer immunotherapy toolbox?
Annals of Lymphoma
2018;
2:
2
.
(20 March 2018)
Review Article
Phosphatidyl-inositol 3-kinase inhibitors in the treatment of T-cell lymphomas
Annals of Lymphoma
2018;
2:
1
.
(05 January 2018)
Review Article
Unmet needs in histological transformation of follicular lymphoma: a clinical and biological review
Annals of Lymphoma
2017;
1:
11
.
(14 December 2017)